Uncategorized

Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend

Published

on

The total of 52 mergers and acquisitions for the first half of 2026 reflects what analysts, industry watchers and executives are saying over and over: M&A is back.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version